Cesca Therapeutics Inc. to Present at Biotech Showcase on Tuesday, January 9, 2018

RANCHO CORDOVA, Calif., Jan. 02, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. ("Cesca") KOOL a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced that Chris Xu, Ph.D., chief executive officer, will be presenting at Biotech Showcase on Tuesday, January 9, 2018 at 4:00pm PST. The conference is being held January 8-10, 2018 at the Hilton San Francisco Union Square.

A live webcast of the presentation will be available at:

https://event.webcasts.com/starthere.jsp?ei=1176627&tp_key=d941414f85. The webcast will be archived for 90 days.

About Cesca Therapeutics Inc. 

Cesca is a leading regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. Its device division, ThermoGenesis, provides a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Cesca is also leveraging its proprietary AutoXpress® technology platform to develop an automated, functionally-closed CAR-TXpress platform that addresses cellular manufacturing needs in the immuno-oncology field.

Company Contact:

Cesca Therapeutics Inc.

Wendy Samford

916-858-5191

ir@cescatherapeutics.com

Investor Contact:

Rx Communications

Paula Schwartz

917-322-2216

pschwartz@rxir.com

Primary Logo

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Press Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!